Indegene Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indegene Ltd. on BSE

Load latest

Indegene Ltd.

31 Jan 2025

579.20

2.18%

Company Update

Indegene Ltd - 544172 - Intimation Of Opening Of Trading Window .

BSE India

This is to inform that pursuant to the SEBI(PIT) regulation 2015 and the Company''s Code of Conduct, Trading Window for dealing in securities of the company by its Designated Person will be open from Sunday, February 2,2025.

pdf

Indegene Ltd.

31 Jan 2025

579.20

2.18%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to regulation 47 of SEBI(LODR),2015,please find enclosed copies of newspaper advertisement published in Financial express and vishwani today, relating to financial results for the quarter ended December 31,2024.

pdf

Indegene Ltd.

31 Jan 2025

579.20

2.18%

Indegene Results Earnings Call for Q3FY25

Conference Call with Indegene Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Indegene Ltd.

30 Jan 2025

579.20

2.18%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

BSE India

Pursuant to Regulation 30 of SEBI[LODR] Regulation, 2015, we hereby inform you that the Board of Directors of Indegene Limited at its meeting held today that is January 30, 2025 has recommended to the shareholders, the appointment of Deloitte Haskins and Sells[DHS] , Registration No: 008072S as Statutory Auditors of the company for a term of 5 years from the conclusion of 27th AGM till the conclusion of 32nd AGM of the company. The Board considered the matter that the tenure of the existing Statutory Auditor of the company BSR &Co LLP FRN: [101248W/W-100022] will end at the 27th AGM of the company.

pdf

Indegene Ltd.

30 Jan 2025

579.20

2.18%

Investor Presentation

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI [LODR] Regulation, 2015, the Analyst presentation and fact sheet for the Q3FY25 with respect to financial results for the quarter ended December 31, 2024 are hereby enclosed.

pdf

Indegene Ltd.

30 Jan 2025

579.20

2.18%

to see Rapid results content

Indegene Ltd.

30 Jan 2025

579.20

2.18%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

We wish to inform you that the company has made a press release dated January 30, 2025, announcing the financial results for the quarter ended December 31, 2024 as approved by the board of Directors at its meeting on January 30, 2025

pdf

Indegene Ltd.

30 Jan 2025

579.20

2.18%

Result

Indegene Ltd - 544172 - Results, Financial Results- Dec 2024

BSE India

The unaudited consolidated financial results of the company and its subsidiaries as per [INDAS] for the quarter ended December 31, 2024 along with the Limited review report of the Auditors thereon. The unaudited standalone financial results of the company as per [INDAS] for the quarter ended December 31, 2024 along with the limited review report of the Auditors thereon. To Allot shares under ESOP 2020 plan & RSU 2020 plan.

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	758.10	708.20	686.45	7.0%	10.4%
Operating Profit Qtr	131.80	126.10	148.81	4.5%	-11.4%
Net Profit Qtr	109.70	91.70	98.50	19.6%	11.4%
Earning Per Share Adjusted latest Qtr	4.58	3.83	4.12	19.6%	11.2%

* Consolidated data

Detailed Results

Indegene Ltd.

30 Jan 2025

579.20

2.18%

Board Meeting

Indegene Ltd - 544172 - Board Meeting Outcome for Intimation Of Outcome Of Board Meeting

BSE India

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of Indegene Limited at its meeting held today, i.e., January 30, 2025, has approved the following: 1. The unaudited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter December 31 ,2024 along with the limited review report of the Auditors thereon. 2. The unaudited standalone financial results of the Company as per INDAS for the quarter December 31,2024 along with the limited review report of the Auditors thereon. 3. To Allot shares under ESOP 2020 plan & RSU 2020 plan

pdf

Indegene Ltd.

24 Jan 2025

579.20

2.18%

Company Update

Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015: Indegene Q3FY25 Earnings Call Friday, January 31st 2025, 9:00AM IST Indegene Limited. invites you to interact with the senior management on Q3FY25 earnings. Speakers: Manish Gupta, Chairman & Chief Executive Officer Suhas Prabhu, Chief Financial Officer